Class information for:
Level 1: DRUG LAG//JAPANESE CLINICAL TRIALS//GLOBAL DRUG DEVELOPMENT

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
26445 254 20.7 43%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
1 4 ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL 3876184
320 3       AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION//MEDICATION ERRORS//AMERICAN JOURNAL OF HOSPITAL PHARMACY 39312
1464 2             FOOD AND DRUG LAW JOURNAL//CONFLICT OF INTEREST//ORPHAN DRUGS 7747
26445 1                   DRUG LAG//JAPANESE CLINICAL TRIALS//GLOBAL DRUG DEVELOPMENT 254

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 DRUG LAG authKW 808122 4% 61% 11
2 JAPANESE CLINICAL TRIALS authKW 480871 2% 100% 4
3 GLOBAL DRUG DEVELOPMENT authKW 429346 2% 71% 5
4 OFF PHARMACEUT IND address 429346 2% 71% 5
5 CLIN TRIAL GUIDANCE address 360653 1% 100% 3
6 REVIEW AUDIT address 360653 1% 100% 3
7 PHARMACEUT REGULATORY SCI address 334509 3% 35% 8
8 ETHNIC FACTORS authKW 274772 3% 29% 8
9 STUDY DRUG DEV address 243427 4% 23% 9
10 DRUG INFORMATION JOURNAL journal 241989 19% 4% 47

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Pharmacology & Pharmacy 3413 67% 0% 169
2 Health Care Sciences & Services 2833 23% 0% 58
3 Medical Informatics 416 5% 0% 13
4 Health Policy & Services 102 4% 0% 9
5 Medicine, Research & Experimental 65 7% 0% 18
6 Oncology 52 9% 0% 24
7 Biotechnology & Applied Microbiology 28 6% 0% 15
8 Integrative & Complementary Medicine 19 1% 0% 3
9 Ethics 11 1% 0% 2
10 Medicine, General & Internal 10 5% 0% 12

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 OFF PHARMACEUT IND 429346 2% 71% 5
2 CLIN TRIAL GUIDANCE 360653 1% 100% 3
3 REVIEW AUDIT 360653 1% 100% 3
4 PHARMACEUT REGULATORY SCI 334509 3% 35% 8
5 STUDY DRUG DEV 243427 4% 23% 9
6 ONCOLCHUO KU 240436 1% 100% 2
7 PHARMACEUT MED DEVICES EVALUAT 154556 2% 21% 6
8 ABT CHEM BIOL CHEM 120218 0% 100% 1
9 BEIJING CHINESE MAT MEDICA QUAL EVALUAT 120218 0% 100% 1
10 BUNKYO GREEN COURT OFF 120218 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 DRUG INFORMATION JOURNAL 241989 19% 4% 47
2 THERAPEUTIC INNOVATION & REGULATORY SCIENCE 55944 5% 4% 13
3 CLINICAL RESEARCH AND REGULATORY AFFAIRS 28344 2% 5% 5
4 CONTEMPORARY CLINICAL TRIALS 5476 3% 1% 8
5 CLINICAL PHARMACOLOGY & THERAPEUTICS 5274 6% 0% 16
6 JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS 4530 4% 0% 9
7 NAGOYA JOURNAL OF MEDICAL SCIENCE 3484 1% 1% 3
8 JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES 2776 2% 1% 4
9 YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN 1859 4% 0% 9
10 JOURNAL OF BIOPHARMACEUTICAL STATISTICS 1178 1% 0% 3

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 DRUG LAG 808122 4% 61% 11 Search DRUG+LAG Search DRUG+LAG
2 JAPANESE CLINICAL TRIALS 480871 2% 100% 4 Search JAPANESE+CLINICAL+TRIALS Search JAPANESE+CLINICAL+TRIALS
3 GLOBAL DRUG DEVELOPMENT 429346 2% 71% 5 Search GLOBAL+DRUG+DEVELOPMENT Search GLOBAL+DRUG+DEVELOPMENT
4 ETHNIC FACTORS 274772 3% 29% 8 Search ETHNIC+FACTORS Search ETHNIC+FACTORS
5 ASIAN CLINICAL TRIAL NETWORK 240436 1% 100% 2 Search ASIAN+CLINICAL+TRIAL+NETWORK Search ASIAN+CLINICAL+TRIAL+NETWORK
6 CLINICAL GRANT 240436 1% 100% 2 Search CLINICAL+GRANT Search CLINICAL+GRANT
7 DRUG MASTER FILE 240436 1% 100% 2 Search DRUG+MASTER+FILE Search DRUG+MASTER+FILE
8 FDA MODERNIZATION ACT OF 1997 240436 1% 100% 2 Search FDA+MODERNIZATION+ACT+OF+1997 Search FDA+MODERNIZATION+ACT+OF+1997
9 FOOD AND DRUG ADMINISTRATION MODERNIZATION 240436 1% 100% 2 Search FOOD+AND+DRUG+ADMINISTRATION+MODERNIZATION Search FOOD+AND+DRUG+ADMINISTRATION+MODERNIZATION
10 GDUFA 240436 1% 100% 2 Search GDUFA Search GDUFA

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 MAEDA, H , KUROKAWA, T , (2015) REGULATORY REVIEW TIME FOR APPROVAL OF ONCOLOGY DRUGS IN JAPAN BETWEEN 2001 AND 2014. CONSIDERATIONS OF CHANGES, FACTORS THAT AFFECT REVIEW TIME, AND DIFFERENCE WITH THE UNITED STATES.JOURNAL OF CLINICAL PHARMACOLOGY. VOL. 55. ISSUE 5. P. 481 -489 10 91% 2
2 MAEDA, H , KUROKAWA, T , (2015) RECENT TRENDS FOR DRUG LAG IN CLINICAL DEVELOPMENT OF ONCOLOGY DRUGS IN JAPAN: DOES THE ONCOLOGY DRUG LAG STILL EXIST IN JAPAN?.INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY. VOL. 20. ISSUE 6. P. 1072 -1080 12 67% 1
3 NAKAJIMA, K , DAGHER, R , STRAWN, L , URUSHIDANI, J , KUROKAWA, T , CHIBA, K , (2015) THE RELATIONSHIP BETWEEN DEVELOPMENT START LAG AND APPROVAL LAG IN ONCOLOGY DRUG DEVELOPMENT IN JAPAN.THERAPEUTIC INNOVATION & REGULATORY SCIENCE. VOL. 49. ISSUE 6. P. 911 -919 8 89% 0
4 ARNOLD, FL , FUKUNAGA, S , KUSAMA, M , MATSUKI, N , ONO, S , (2014) ASSESSMENT OF FACTORS ASSOCIATED WITH DOSE DIFFERENCES BETWEEN JAPAN AND THE UNITED STATES.CLINICAL PHARMACOLOGY & THERAPEUTICS. VOL. 95. ISSUE 5. P. 542-549 12 57% 4
5 NAKAJIMA, K , CHIBA, K , TSUBAMOTO, H , WALSH, J , STRAWN, L , SUWA, T , (2013) POTENTIAL FACTORS CORRELATING TO THE PMDA'S DECISION TO WAIVE JAPANESE PHASE 2 AND 3 STUDIES FOR ONCOLOGY DRUGS NEW DRUG APPLICATION IN JAPAN.INVESTIGATIONAL NEW DRUGS. VOL. 31. ISSUE 4. P. 1051-1055 7 100% 0
6 OHWAKI, K , NAKABAYASHI, T , (2014) RELATIONSHIP BETWEEN DRUG LAG AND FACTORS ASSOCIATED WITH CLINICAL TRIALS IN JAPAN.JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. VOL. 39. ISSUE 6. P. 649 -652 6 100% 2
7 ISHIBASHI, T , KUSAMA, M , SUGIYAMA, Y , ONO, S , (2012) ANALYSIS OF REGULATORY REVIEW TIMES OF NEW DRUGS IN JAPAN: ASSOCIATION WITH CHARACTERISTICS OF NEW DRUG APPLICATIONS, REGULATORY AGENCY, AND PHARMACEUTICAL COMPANIES.JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. VOL. 37. ISSUE 6. P. 657-663 9 69% 3
8 SHIMAZAWA, R , IKEDA, M , (2011) DELAYS IN NEUROLOGICAL DRUG DEVELOPMENT IN JAPAN.INTERNAL MEDICINE. VOL. 50. ISSUE 15. P. 1565-1568 6 100% 3
9 TANIMOTO, T , (2015) A PERSPECTIVE ON THE BENEFIT-RISK ASSESSMENT FOR NEW AND EMERGING PHARMACEUTICALS IN JAPAN.DRUG DESIGN DEVELOPMENT AND THERAPY. VOL. 9. ISSUE . P. 1877 -1888 12 43% 0
10 SHIMAZAWA, R , KUSUMI, I , IKEDA, M , (2012) DELAYS IN PSYCHIATRIC DRUG DEVELOPMENT IN JAPAN.JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS. VOL. 37. ISSUE 3. P. 348-351 9 60% 4

Classes with closest relation at Level 1


Rank Class id link
1 16184 ORPHAN DRUGS//RARE DISEASES//ORPHAN DRUG ACT
2 21788 CRHAM//SOCIOL SUBJECT GRP//CORPORATE BIAS
3 34994 FOCAL FIBROCARTILAGINOUS DYSPLASIA//FIBROUS TETHER//MOLECULAR TUMOUR THERAPY
4 16867 CLINICAL TRIAL RISK//DRUG DISCOVERY TODAY//TUFTS STUDY DRUG DEV
5 30020 BENEFIT RISK//BENEFIT RISK ASSESSMENT//BENEFIT RISK COMMUNICATION
6 16116 SUBGROUP ANALYSIS//MULTIREGIONAL CLINICAL TRIAL//MULTIREGIONAL TRIAL
7 26659 HEALTH INSURANCE CLAIMS//RULE OUT DIAGNOSIS//UNCODED DIAGNOSES
8 5560 GENERIC SUBSTITUTION//GENERIC DRUGS//GENERIC MEDICINES
9 25741 ANTIBACTERIAL DRUG DEVELOPMENT//INFECT GLOBAL MED DEV//ANTIBIOTIC INNOVATION
10 28567 CODISPENSING//RISK EVALUATION AND MITIGATION STRATEGIES//BOXED WARNINGS

Go to start page